DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo

170.09 -5.10 (-2.91%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

JAZZ $170.09 -2.91%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $175.53
Previous Close $175.19
Daily Range $169.72 - $176.40
52-Week Range $120.38 - $183.84
Market Cap $10.3B
P/E Ratio 188.38
Dividend (Yield) $0.00 (0.0%)
Volume 746,892
Average Daily Volume 640,914
Current FY EPS $8.31

Sector

Healthcare

Industry

Drug Makers

Jazz Pharmaceuticals, Inc. (JAZZ) Description

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Website: http://www.jazzpharmaceuticals.com/

News & Commentary Rss Feed

Top Pharmaceutical Stocks to Buy for 2015

Three fast-growing pharmaceutical stocks that investors may want to consider owning in 2015.

Play This "Hidden" M&A Boom – and Beat the Market for the Next Two Years

Company News for February 26, 2015 - Corporate Summary

Heavy News Day For Several Biotech Stocks

Jazz Pharmaceuticals Tops Q4 Earnings, Provides Guidance - Analyst Blog

8 Stories JP Morgan Is Watching Today

Jazz Pharmaceuticals (JAZZ) Earnings Report: Q4 2014 Conference Call Transcript

Jazz Pharmaceuticals' (JAZZ) CEO Bruce Cozadd on Q4 2014 Results - Earnings Call Transcript

Jazz Pharmaceuticals Sinks On Outlook, Halt In Drug Trial

Earnings Reaction History: Jazz Pharmaceuticals, Inc., 20.0% Follow-Through Indicator, 2.9% Sensitiv

Earnings Reaction History: Jazz Pharmaceuticals, Inc., 20.0% Follow-Through Indicator, 2.9% Sensitive

After-Hours Earnings Report for February 24, 2015 : HPQ, EIX, CLR, VRSK, JAZZ, NLY, AWK, RRC, Y, FS

After-Hours Earnings Report for February 24, 2015 : HPQ, EIX, CLR, VRSK, JAZZ, NLY, AWK, RRC, Y, FSLR, NDSN, CPRT

See More JAZZ News...

JAZZ's Top Competitors

JAZZ $170.09 (-2.91%)
Current stock: JAZZ
NVS $102.40 (-0.58%)
Current stock: NVS
PFE $34.32 (-0.78%)
Current stock: PFE
JNJ $102.51 (-0.28%)
Current stock: JNJ